ProAssurance Corporation

NYSE (USD): ProAssurance Corporation (PRA)

Last Price

17.22

Today's Change

+0.05 (0.29%)

Day's Change

17.22 - 17.34

Trading Volume

10,659

Profile
PRA

Exchange:  New York Stock Exchange New York Stock Exchange

Currency:  USD USD

Sector:  Financial Services - Financial Services Financial Services - Financial Services

Industry: 

CEO:  Mr. Edward Lewis Rand Jr., CPA Mr. Edward Lewis Rand Jr., CPA

Full Time Employees:  1,094 1,094

IPO Date:  1991-09-04 1991-09-04

CIK:  0001127703 0001127703

ISIN:  US74267C1062 US74267C1062

CUSIP:  74267C106 74267C106

Beta:  0.26 0.26

Last Dividend:  0.00 0.00

Dcf Diff:  -14.67 -14.67

Dcf:  31.84 31.84

Description

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Lloyd's Syndicate segments. It offers professional liability insurance for healthcare providers and institutions, and attorneys; liability insurance for medical technology and life sciences risks; and workers' compensation insurance, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Lloyd's of London Syndicate 1729, which underwrites property and casualty insurance, and reinsurance. It markets its products through independent agencies and brokers, as well as an internal sales force. The company was founded in 1976 and is headquartered in Birmingham, Alabama.

Address

100 Brookwood Place,
Birmingham, AL 35209, US

205 877 4400

http://www.proassurance.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment